Journal of Applied Physiology Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 84: 2163-2170, 1998;
8750-7587/98 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosen, M. J.
Right arrow Articles by Katzel, L. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosen, M. J.
Right arrow Articles by Katzel, L. I.
Vol. 84, Issue 6, 2163-2170, June 1998

MODELING IN PHYSIOLOGY
Predictors of age-associated decline in maximal aerobic capacity: a comparison of four statistical models

Mitchell J. Rosen1, John D. Sorkin1,2, Andrew P. Goldberg1, James M. Hagberg1,3, and Leslie I. Katzel1

1 Division of Gerontology, Department of Medicine, University of Maryland, and Geriatric Research, Education, and Clinical Center, Geriatrics Service, Baltimore Veterans Affairs Medical Center, Baltimore 21201; 2 Laboratory of Clinical Investigation, Metabolism Section, National Institute on Aging, Baltimore 21224; and 3 Department of Kinesiology, University of Maryland, College Park, Maryland 20742

    ABSTRACT
Top
Abstract
Introduction
Materials
Results
Discussion
References

Studies assessing changes in maximal aerobic capacity (VO2 max) associated with aging have traditionally employed the ratio of VO2 max to body weight. Log-linear, ordinary least-squares, and weighted least-squares models may avoid some of the inherent weaknesses associated with the use of ratios. In this study we used four different methods to examine the age-associated decline in VO2 max in a cross-sectional sample of 276 healthy men, aged 45-80 yr. Sixty-one of the men were aerobically trained athletes, and the remainder were sedentary. The model that accounted for the largest proportion of variance was a weighted least-squares model that included age, fat-free mass, and an indicator variable denoting exercise training status. The model accounted for 66% of the variance in VO2 max and satisfied all the important general linear model assumptions. The other approaches failed to satisfy one or more of these assumptions. The results indicated that VO2 max declines at the same rate in athletic and sedentary men (0.24 l/min or 9%/decade) and that 35% of this decline (0.08 l · min-1 · decade-1) is due to the age-associated loss of fat-free mass.

exercise; heteroscedasticity; weighted least squares; log-linear model; ratio

    INTRODUCTION
Top
Abstract
Introduction
Materials
Results
Discussion
References

THERE IS AN AGE-ASSOCIATED decline in maximal aerobic capacity (VO2 max) in trained and untrained men (6, 8, 10, 13, 22). This age-associated decline in VO2 max is due to many factors, including decreases in maximum heart rate, stroke volume, arteriovenous O2 difference, and skeletal muscle mass and an increase in adiposity (10, 13, 22). Changes in physical activity habits, leading to a sedentary lifestyle, also contribute to the age-associated decline in VO2 max (3, 12, 17, 22, 27). There is conflicting evidence on whether regular aerobic exercise training attenuates the age-associated decline in VO2 max (13, 25, 28).

Different statistical models have been used to analyze the relationships among the physiological variables associated with the age-associated decline in VO2 max. The statistical approach employed to adjust the VO2 max for body size and composition must be considered carefully; the approach must be statistically valid. All other factors being equal, a larger individual would be expected to have a higher VO2 max than a smaller individual. To account for differences in body habitus, the simple ratio of VO2 max to a measure of body size [e.g., VO2 max ml · kg body wt-1 · min-1 or VO2 max ml · kg fat-free mass (FFM)-1 · min-1] is often used as the dependent variable in studies of the age-related decline in VO2 max (3, 12, 27). We will refer to this model as the ratio standard (RS) model. The use of ratios as dependent variables in regression models has been criticized for a variety of reasons (2, 9, 20, 28, 30, 31, 33), but the main drawback is that the ratio Y/X is correlated with X (21, 32, 33). In a classic paper, Pearson (23) showed that if X, Y, and Z are three random variables and X, Y, and Z are uncorrelated, X/Z and Y/Z are correlated under minimally restrictive assumptions (23). In the case of VO2 max, the VO2 max/body size ratio may not make VO2 max totally independent of body size. Given the physiological and functional importance of the VO2 max-age relationship, it is important that this relationship is assessed in valid statistical and mathematical terms to ensure appropriate interpretation of the results.

Two alternatives to the RS model have been used in the statistical analysis of the age-related change in VO2 max: ordinary least-squares (OLS) regression of VO2 max on a measure of body size, such as FFM or weight (31), and log-linear (LL) or allometric models (20, 21). OLS and LL models are not without problems. OLS residuals in VO2 max models are often heteroscedastic; i.e., they increase in variability as the measure of body habitus increases (20, 33). Heteroscedasticity can affect the standard errors of the parameter estimates and thus adversely affect tests of significance (24). LL models have been criticized for their tendency to overfit biological data, modeling what is sometimes a linear phenomenon with a nonlinear model (1). Additionally, LL models assume a zero intercept, which usually involves extrapolation well beyond the range of observed data (1). A variant of LL is the Box-Cox transformation (4), in which the dependent variable is raised to the power (i.e., VO2 maxgamma ) that maximizes the likelihood that the model residuals follow a normal distribution. This method has not been widely used in studies that have examined the age-associated decline in VO2 max.

In this paper an alternative method to modeling VO2 max is proposed: weighted least squares (WLS). WLS models retain the advantages of OLS models, producing "best linear unbiased estimates" (BLUE) and overcoming the problem of heteroscedasticity (16, 24). Because of the widespread use of the RS models in studies of VO2 max, the potential errors caused by the failure of the RS to remove the effect of body size on VO2 max, and the potential problems caused by the heteroscedasticity inherent in OLS models of VO2 max, we believe that further analysis of the age-related decline in VO2 max is warranted. Therefore, we compare the results obtained from RS, OLS, LL, and WLS models of the age-associated decline in VO2 max. In each case we examine how well the model satisfies the general linear model (GLM) assumptions of normality and homoscedasticity.

    METHODS AND MATERIALS
Top
Abstract
Introduction
Materials
Results
Discussion
References

Subjects

This study was approved by the Institutional Review Boards of the University of Maryland School of Medicine and Johns Hopkins University Bayview Medical Center. All subjects provided informed consent before participation. Over an 8-yr period, healthy nonsmoking men, ages 45-80 yr, with no prior history of cardiovascular disease and a wide range of body mass index (BMI) and physical conditioning status, were recruited to participate in exercise training and weight loss studies (14, 35). Characteristics of the subjects are summarized in Table 1. All subjects underwent a history and physical examination and evaluation of fasting blood chemistries. Subjects were healthy and on no medications. Exclusion criteria included history of coronary artery disease (by clinical history and electrocardiogram), pulmonary disease, hypertension (blood pressure >= 160/90 mmHg), hyperlipidemia, diabetes mellitus (fasting plasma glucose >= 140 mg/dl), or any other significant medical problems that would interfere with their ability to undergo maximal exercise treadmill testing. The study sample included a cohort of 61 healthy athletes recruited from participants of the Maryland Senior Olympics and athletic clubs in the Baltimore-Washington metropolitan area and 215 sedentary subjects (35). The sedentary subjects exercised <20 min twice per week. The athletes exercised vigorously at least four times per week and had <25% body fat by hydrodensitometry.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Subject characteristics

Measurement of Body Composition

Height and weight were measured, and BMI was computed as the ratio of body weight in kilograms to height in meters squared. Body surface area in meters squared was calculated as (height in cm)0.718 × (weight in kg)0.427 × 0.007449 (7). Body density was determined by hydrostatic weighing, with percent body fat calculated after correction for residual lung volume with use of the Siri model (29). FFM was calculated as body weight minus fat mass.

Measurement of VO2 max

An exercise treadmill test to >= 85% of the predicted age-adjusted heart rate (220 - age) was performed according to the protocol of Bruce and Horsten (5) to exclude subjects with previously undiagnosed heart disease. On a subsequent visit the VO2 max was determined using a modified Balke protocol, as previously described (14). The grade of the treadmill was increased every 2 min until the subject was exhausted and could not continue (14). The VO2 max tests fulfilled at least two of the three following criteria: 1) the heart rate at maximal exercise was >= 85% of the age-adjusted maximal heart rate, 2) the respiratory exchange quotient was >1.10, and 3) there was a plateau in O2 consumption defined as a change in O2 consumption of <0.2 l/min during the final two collection periods. Absolute VO2 max, measured in liters per minute, is used in the statistical modeling.

Statistical Analysis

All statistical analyses were performed using SAS version 6.11 run on the Windows 3.1 operating system.

Statistical models of VO2 max. Four statistical models were used to determine the age-associated decline in VO2 max.

1) The form of the RS model is
<A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 max</SUB>/FFM = &bgr;<SUB>0</SUB> + &bgr;<SUB>1</SUB><IT>X</IT><SUB>1</SUB> + &bgr;<SUB>2</SUB><IT>X</IT><SUB>2</SUB> +, …, +&egr; (1)
where X1, X2, etc., are independent variables, beta 0, beta 1, etc., are parameters, and epsilon  is a normally and independently distributed error term having equal variance for all levels of the independent variable(s) in the target population.

2) The form of the OLS regression is
<A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 max</SUB> = &bgr;<SUB>0</SUB> + &bgr;<SUB>1</SUB>FFM + &bgr;<SUB>2</SUB><IT>X</IT><SUB>2</SUB> +, …, +&egr; (2)
where FFM (= X1), X2, etc., are independent variables, beta 0, beta 1, etc., are parameters, and epsilon  is an error term with the same properties as in Eq. 1. OLS estimation ensures that the residuals of the model are uncorrelated with FFM, X2, etc. (24).

3) The univariate form of the LL model is
<A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 max</SUB> = &bgr;<SUB>0</SUB>FFM<SUP>&bgr;<SUB>1</SUB></SUP>&dgr; (3)
where beta 0 and beta 1 are parameters and delta  is an error term. Equation 3 is referred to as an allometric model. The multivariable form is
<A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 max</SUB> = &bgr;<SUB>0</SUB>FFM<SUP>&bgr;<SUB>1</SUB></SUP><IT>X</IT><SUP>&bgr;<SUB>2</SUB></SUP><SUB>2</SUB>, … , <IT>X</IT><SUP>&bgr;<SUB><IT>p</IT></SUB></SUP><SUB><IT>p</IT></SUB>
exp(&bgr;<SUB><IT>p</IT>+1</SUB> <IT>W</IT><SUB>1</SUB> + &bgr;<SUB><IT>p</IT>+2</SUB> <IT>W</IT><SUB>2</SUB> +, …, &bgr;<SUB><IT>p</IT>+<IT>k</IT></SUB> <IT>W<SUB>k</SUB></IT>)&dgr; (4)
where FFM (= X1), X2, etc., are variables related in an LL manner to VO2 max, W1, W2, etc., are variables related linearly to VO2 max, beta 0, beta 1, etc., are parameters, and delta  is an error term. For example, when age is used in the multivariable model, Eq. 4 becomes
<IT>Y</IT> = <IT>b</IT><SUB>0</SUB>FFM<SUP><IT>b</IT><SUB>1</SUB></SUP> exp(<IT>b</IT><SUB>2</SUB> AGE)&dgr; (5)
One approach to estimating the parameters of the univariate or multivariable models is to use OLS on the logarithmic transformation of the model, e.g.
log(<A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 max</SUB>) = log(&bgr;<SUB>0</SUB>) + &bgr;<SUB>1</SUB> log(FFM) + log(&dgr;) (6)
or
log(<A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 max</SUB>) = log(&bgr;<SUB>0</SUB>) + &bgr;<SUB>1</SUB> log(FFM) + &bgr;<SUB>2</SUB> AGE + log(&dgr;) (7)
An alternative approach is to estimate the coefficients in the original scale by use of nonlinear regression methods. In this study the former method was used.

When the univariate form of the LL model is used, it is usual practice to verify that the variable VO2 max/FFMbeta 1, which is proportional to the residuals of Eq. 3, has a correlation near zero with FFM (32, 33).

4) WLS regression is identical to OLS regression, except each subject i receives a weight wi. The goal of WLS is to minimize the sums of the squares
<LIM><OP>∑</OP><LL><IT>i</IT>=1</LL><UL><IT>n</IT></UL></LIM> <IT>w<SUB>i</SUB></IT> <FENCE><A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 max<SUB><IT>i</IT> (obs)</SUB></SUB> − <A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 max<SUB><IT>i</IT> (pred)</SUB></SUB></FENCE><SUP>2</SUP> (8)
where the first and second terms in parentheses are the observed and predicted VO2 max values, respectively. In OLS, wi = 1 (for all i). For example, if the error variance increases along with the values of a regressor (e.g., FFM), observations that have higher values on the regressor receive lower weights than observations that have lower values. The model then reflects the greater uncertainty in the predicted values at higher values of the regressor.

If the weights are chosen to be proportional to the reciprocal of the error variance and the other GLM assumptions are met, the WLS model has the desirable property of producing parameter estimates that are BLUE. Moreover, the estimated variances of the parameters will be unbiased and so will the t-tests on which these variances are based. If heteroscedasticity exists, the estimates of the variance of the parameters produced by OLS are not minimum variance estimates, so OLS estimates will not, in general, be BLUE (24).

In this study, WLS weights took the form wi = 1/FFMalpha i. When this form is used, the following assumption, known as multiplicative heteroscedasticity, is implied
&sfgr;<SUP>2</SUP><SUB><IT>i</IT></SUB> = &sfgr;<SUP>2</SUP> FFM<SUP>&agr;</SUP><SUB><IT>i</IT></SUB> (9)
In Eq. 9, sigma 2i is the error variance at the level of FFM that equals FFMi, sigma 2 is the error variance from the OLS model, and alpha  is the parameter related to the degree of heteroscedasticity (homoscedasticity implies alpha  = 0). Equation 9 suggests that the variation of the residuals of model shown in Eq. 2 increases as FFM increases. This assumption is usually examined by plotting the fitted residuals <A><AC>&egr;</AC><AC>ˆ</AC></A> against FFM. Harvey (11) provided a method for obtaining the maximum likelihood (ML) estimator of alpha . Other ways of obtaining the ML estimates of sigma 2 and alpha  have been proposed (16).

It is possible to demonstrate that using the weights 1/FFMalpha i is equivalent to transforming the linear model by dividing each term by FFMalpha /2i (24). For example, if FFM is the only regressor, the transformed model is
<A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 max</SUB>/FFM<SUP>&agr;/2</SUP> = (&bgr;<SUB>0</SUB>/FFM<SUP>&agr;/2</SUP>) + &bgr;<SUB>1</SUB>FFM<SUP>1−&agr;/2</SUP>  (10)
+ (&egr;/FFM<SUP>&agr;/2</SUP>)
The model can be estimated by fitting the regression on the transformed variables.

Equation 10 shows that the variance of the transformed residuals is constant as long as the weights wi are proportional to the reciprocal of the error variance. Given the usual regression assumption that the independent variables are fixed, we can write the variance of the error term as
var(&egr;<SUB><IT>i</IT></SUB>/FFM<SUP>&agr;/2</SUP><SUB><IT>i</IT></SUB>) = (1/FFM<SUP>&agr;</SUP><SUB><IT>i</IT></SUB>) var(&egr;<SUB><IT>i</IT></SUB>) (11)
Now, apply Eq. 9, setting sigma 2i = var(epsilon i)
(1/FFM<SUP>&agr;</SUP><SUB><IT>i</IT></SUB>) var(&egr;<SUB><IT>i</IT></SUB>) = (1/FFM<SUP>&agr;</SUP><SUB><IT>i</IT></SUB>)&sfgr;<SUP>2</SUP>FFM<SUP>&agr;</SUP><SUB><IT>i</IT></SUB> = &sfgr;<SUP>2</SUP> (12)
There is another interesting consequence of Eq. 10. If alpha  = 2, Eq. 10 becomes
<A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 max</SUB>/FFM = &bgr;<SUB>0</SUB>/FFM + &bgr;<SUB>1</SUB> + &egr;/FFM (13)
Then, if beta 0 = 0 (zero intercept), Eq. 13 is structurally identical to the RS model (Eq. 1) with only an intercept term. This suggests that if alpha  = 2 and beta 0 = 0, the RS model (Eq. 13) will be homoscedastic. Moreover, if the transformation does not greatly perturb the correlation matrix, multivariable RS models should also have this property, given the previous assumptions.

It is possible to extend Eq. 9 to include multiple regressors, e.g.
&sfgr;<SUP>2</SUP><SUB><IT>i</IT></SUB> = &sfgr;<SUP>2</SUP> FFM<SUP>&agr;<SUB>1</SUB></SUP><SUB><IT>i</IT></SUB> HEIGHT<SUP>&agr;<SUB>2</SUB></SUP><SUB><IT>i</IT></SUB> (14)
The weights for WLS derived from Eq. 10 are 1/(FFMalpha 1i)HEIGHTalpha 2i. Note that the regressors in Eq. 9 or 14 need not necessarily be regressors in the OLS model (Eq. 2).

Factors related to the age-associated decline in VO2 max. We initially examined models that included age, FFM, body weight, fat mass, height, BMI, body surface area, and a dichotomous exercise training variable (ET) that denoted whether the individual was an athlete (0 = sedentary, 1 = athlete). Body weight, fat mass, BMI, height, and body surface area were not significant predictors in any of the models at the 0.05 level when FFM was included and were not included in the analyses.

To determine whether the slopes of the age-related decline in VO2 max differed between athletes and sedentary subjects, analyses were also performed with RS, OLS, and WLS models that included interactions between age and ET. For each model type we obtained estimates of the age-associated decline and effect of ET on VO2 max. Because the LL model is log linear, it does not permit a test of the hypothesis of parallel linear declines in VO2 max.

Contribution of skeletal muscle loss to the age-associated decline in VO2 max. We estimated the contribution of the loss of skeletal muscle to the decline in VO2 max as
%contribution = 100 ⋅ <FR><NU>&bgr;<SUB>AGE (adjusted)</SUB> − &bgr;<SUB>AGE (unadjusted)</SUB></NU><DE>&bgr;<SUB>AGE (unadjusted)</SUB></DE></FR> (15)
where beta AGE(adjusted) and beta AGE(unadjusted) are the regression coefficients for age in the models adjusted and unadjusted for FFM, respectively
Linear
unadjusted <A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 max</SUB> = &bgr;<SUB>0</SUB> + &bgr;<SUB>1</SUB> AGE + &bgr;<SUB>2</SUB> ET + &egr; (16)
adjusted <A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 max</SUB> = &bgr;<SUB>0</SUB> + &bgr;<SUB>1</SUB> AGE + &bgr;<SUB>2</SUB> ET  (17)
+ &bgr;<SUB>3</SUB> FFM + &egr;
Log-linear
unadjusted <A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 max</SUB> = &bgr;<SUB>0</SUB> exp(&bgr;<SUB>2</SUB> AGE + &bgr;<SUB>3</SUB> ET)&dgr; (18)
adjusted <A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 max</SUB> = &bgr;<SUB>0</SUB> FFM<SUP>&bgr;<SUB>1</SUB></SUP> exp(&bgr;<SUB>2</SUB> AGE + &bgr;<SUB>3</SUB> ET)&dgr; (19)

Tests of assumptions. A key issue in the selection of an appropriate mathematical model for describing a set of data is whether the model fulfills the appropriate underlying statistical assumptions. It was therefore important to examine the distribution of the residuals in the various models for heteroscedasticity. For OLS models that contained FFM we used the likelihood ratio test provided by Harvey (11) to determine the presence of multiplicative heteroscedasticity (Eqs. 9 and 14). For LL models we assessed multiplicative heteroscedasticity by computing the correlation between the absolute value of the residuals and FFM (24). Even if multiplicative heteroscedasticity is not present, other forms of heteroscedasticity may exist. We used the method of White (34) to test for the possibility of other forms of heteroscedasticity. This test is sensitive to heteroscedasticity if it causes the variance-covariance matrix of the OLS estimators to vary from its asymptotic (large sample) form (15). Variation from the asymptotic form can result if one or more of the linear model assumptions are not satisfied. We used the Wilks-Shapiro test to test for violations of normality. White's test and the Wilks-Shapiro test were obtained from SAS proc reg and proc univariate, respectively. SAS proc IML was used to obtain the ML estimate of alpha  and to compute the likelihood ratio test for the hypothesis alpha  = 0. An ML grid search algorithm for estimating alpha  is available in SPSS Professional Statistics 6.1 (WLS procedure).

    RESULTS
Top
Abstract
Introduction
Materials
Results
Discussion
References

The correlations among selected measures of body size, age, and VO2 max are shown in Table 2. All the body size variables correlated with VO2 max (P < 0.01). Regression results for the unadjusted and adjusted RS, OLS, LL, and WLS models are shown in Table 3. Only variables significant at P < 0.05 in the regression are listed.

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Correlations between age, measures of body habitus, and VO2 max

                              
View this table:
[in this window]
[in a new window]
 
Table 3.   Regression results for variables significant at P < 0.05 in models unadjusted and adjusted for body habitus

Effect of Age Unadjusted for Body Habitus

All the parameter estimates of the OLS model
<A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 max</SUB> = &bgr;<SUB>0</SUB> + &bgr;<SUB>1</SUB> AGE + &bgr;<SUB>2</SUB> ET + &egr; (20)
were significant at P < 0.01 (Table 3). This model accounted for 48% of the variance in VO2 max. There was no evidence of lack of normality (Wilks-Shapiro test, P > 0.10) or heteroscedasticity due to lack of fit (White's test, P > 0.7). However, it is of interest that multiplicative heteroscedasticity with FFM was present [Harvey's test, chi 2 (1) = 4.22, P < 0.05]. There was no significant interaction between age and ET. Therefore, the absolute age-associated rate of decline in VO2 max, 0.36 l/min, was the same in athletes and sedentary men. The OLS estimate of the effect of exercise training (the coefficient of ET) was 0.78 l/min (Table 3).

All the parameters of the LL model
<A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 max</SUB> = &bgr;<SUB>0</SUB> exp(&bgr;<SUB>2</SUB> AGE + &bgr;<SUB>3</SUB> ET)&dgr; (21)
were significant at P < 0.01 (Table 3). This model accounted for 46% of the variance in VO2 max. The residuals were normally distributed, but there was evidence of heteroscedasticity due to lack of fit (White's test, P < 0.05). Unlike the OLS and WLS models, in the LL model the percent decline of VO2 max per decade is independent of the baseline value. The age-associated decline was proportional to exp(-0.014 AGE) = 0.986 exp(AGE).

To obtain the WLS model, the OLS model
<A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 max</SUB> = &bgr;<SUB>0</SUB> + &bgr;<SUB>1</SUB> AGE + &bgr;<SUB>2</SUB> ET + &egr; (22)
was adjusted for multiplicative heteroscedasticity by using weights 1/FFM0.87. All the parameter estimates were significant at P < 0.01 (Table 3). This model accounted for 49% of the variance in VO2 max. The WLS model met all the GLM assumptions and yielded estimates of the training effect and of the age-associated decline that were nearly identical to the OLS model.

Effect of Age Adjusted for Body Habitus

The RS model was
<A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 max</SUB>/FFM = &bgr;<SUB>0</SUB> + &bgr;<SUB>1</SUB> AGE + &bgr;<SUB>2</SUB> ET + &egr; (23)
The ratio VO2 max/FFM did not completely remove the effects of FFM; the correlation between the ratio and FFM was -0.17 (P < 0.01). All parameter estimates for the model (Eq. 23) were significant at P < 0.01 (Table 3). The model accounted for 60% of the variance in VO2 max. There was no evidence of heteroscedasticity due to lack of fit and no correlation between the absolute residuals and FFM (r = 0.01). However, the residuals were not normally distributed (P < 0.02). There was no significant interaction between age and ET. Thus the age-associated rate of decline relative to FFM was the same in athletes and sedentary men, ~0.0034 l · kg FFM-1 · min-1 · decade-1. The estimate of the ET effect due to the difference in intercept was 0.016 l/min (Table 3).

For the OLS model
 <A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 max</SUB> = &bgr;<SUB>0</SUB> + &bgr;<SUB>1</SUB> FFM + &bgr;<SUB>2</SUB> AGE + &bgr;<SUB>3</SUB> ET + &egr; (24)
all parameter estimates were significant at P < 0.01. The OLS model accounted for 64% of the variance in VO2 max. There was no evidence of lack of normality or heteroscedasticity due to lack of fit. The absolute residuals correlated with FFM (r = 0.18, P < 0.01). Harvey's test for multiplicative heteroscedasticity confirmed this finding: chi 2 (1) = 7.52, P < 0.01. A plot of the residuals vs. FFM, in which the heteroscedasticity is depicted, is shown in Fig. 1. As in the RS model, the rates of decline were not significantly different in athletes and sedentary men. The calculated decline in VO2 max was 0.24 l · min-1 · decade-1, and the estimate of the exercise conditioning effect was 0.96 l/min.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 1.   Diagnostic scatter plot of ordinary least-squares (OLS) residuals vs. fat-free mass (FFM). Residuals are derived from OLS model maximal aerobic capacity (VO2 max) = 1.84 - 0.024 AGE + 0.96 ET + 0.035 FFM, where ET is exercise training.

For the LL model
<A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 max</SUB> = &bgr;<SUB>0</SUB> FFM<SUP>&bgr;<SUB>1</SUB></SUP> exp(&bgr;<SUB>2</SUB> AGE + &bgr;<SUB>3</SUB> ET)&dgr; (25)
all parameter estimates were significant at P < 0.01. The model accounted for 63% of the variance in VO2 max. However, there was evidence of lack of normality and of heteroscedasticity due to lack of fit (Wilks-Shapiro and White's tests, both P < 0.01). There was no evidence of multiplicative heteroscedasticity; the absolute residuals were uncorrelated with FFM (r = 0.01). For this model the age-associated decline was proportional to exp(-0.009 AGE) = 0.99 exp(AGE), suggesting an 8.4% decline in VO2 max per decade in athletes and sedentary men.

WLS results were based on the OLS model (Eq. 21) using weights 1/FFM1.30. The WLS and OLS estimates and standard errors were almost identical (Table 3). The WLS model explained 66% of the variance in VO2 max compared with 64% for OLS. The residuals met all the important GLM assumptions. As in the RS and OLS models, the rates of decline in VO2 max were the same in trained and untrained men (i.e., there was no significant interaction between age and ET). The WLS model yielded estimates of the training effect and of the age-related declines in VO2 max that were similar in athletes and sedentary men, as in the OLS model. A plot of the decline in VO2 max with age based on the coefficients from the WLS model is shown in Fig. 2.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 2.   Scatter plot of VO2 max vs. age in athletes (open circle ) and sedentary men (+). Dashed and solid lines, best-fit weighted least-squares regression for each group, VO2 max = 1.77 - 0.024 AGE + 0.96 ET + 0.036 FFM, at mean of FFM for entire sample.

Effect of Age Adjusted for FFM and Height

Nevill (19) suggested that height may be an important covariate in LL models of VO2 max. In this study, height was not a significant predictor of VO2 max in any of the models, and its inclusion had little effect on the estimates of the age-associated decline. This may be due in part to the relatively small variation in height (coefficient of variation of 4%) in these subjects. Height also did not contribute when used in the model in Eq. 10 with FFM as a predictor of within-subject variance [Harvey's test chi 2 (1) = 2.64, P > 0.05].

Effect of Age Adjusted for FFM and Fat Mass

Toth et al. (30) suggested that the ratio of FFM to fat mass was an important factor contributing to the age-associated decline in VO2 max. In this study we found that neither fat mass nor the ratio of FFM to fat mass contributed significantly to any of the models (P > 0.05) when FFM was already included.

Contribution of Loss of FFM to the Age-Associated Decline in VO2 max

The OLS, WLS, and LL models suggested that ~35% of the age-associated decline in VO2 max was due to a loss of skeletal muscle. Given that VO2 max declines 0.24 l · min-1 · decade-1, the loss of skeletal muscle accounts for 0.08 l · min-1 · decade-1 of this quantity. Because FFM was not in the RS model as a predictor, the RS model cannot provide an estimate of the contribution of FFM to the age-associated decline in VO2 max.

    DISCUSSION
Top
Abstract
Introduction
Materials
Results
Discussion
References

The WLS regression incorporating age, FFM, and a dichotomous indicator of physical conditioning status yielded a model of VO2 max that accounted for the largest proportion of variance and met all the important GLM assumptions. Absolute R2 for the WLS model was ~6% higher than for the RS model, 3% higher than for the LL model, and 2% higher than for the OLS model (Table 3). These results support the use of WLS models to examine the physiological factors underlying the age-associated decline in VO2 max.

Despite their failure to satisfy the underlying GLM assumptions, the RS and OLS models incorporating age, FFM, and ET provided estimates similar to the WLS model of the age-associated decline in athletes and sedentary men. The RS model incorporating age, FFM, and ET produced estimates that were ~10% lower than those produced by the OLS and WLS models (the LL model suggested an exponential decay in VO2 max). The OLS estimate was nearly identical to the WLS estimate, despite the failure of the OLS model to satisfy the assumption of homoscedasticity. This estimate (0.24 l · min-1 · decade-1) suggests a 9% decline in VO2 max between 60 and 70 yr of age, which is consistent with other studies that indicate that the average healthy sedentary man >25 yr of age is expected to lose 9-11% of his VO2 max per decade (10, 13, 30).

Because the WLS models satisfied all the important GLM assumptions, the estimates produced by the WLS analysis were BLUE, and the t-tests of the regression coefficients were correct. All the other methods failed to satisfy one or more of the assumptions.

Some investigators recommend verifying the assumption of homoscedasticity when scaling for differences in body habitus (20, 33). In this study the findings were generally robust to violation of this assumption. Multiplicative heteroscedasticity did not significantly affect the OLS standard errors, and the OLS model R2 increased slightly compared with the (homoscedastic) RS model. We also found that the estimates were virtually unchanged over the range alpha  = 0-2 (data not shown). This insensitivity of the WLS estimates may have been due to the fact that the correlation between the absolute residuals and FFM was only r = 0.18. It is possible that WLS may have a greater impact on the estimates and standard errors when the correlation is higher, e.g., r > 0.30. Higher correlations have been reported elsewhere (33).

In the log-transformed LL models the residuals displayed lack of normality and heteroscedasticity due to lack of fit. A post hoc analysis (data not shown) determined that both problems were due to the presence of an indicator variable in the analysis. When separate analyses were carried out within the athlete and sedentary groups, the residuals were normally distributed and homoscedastic. Heteroscedasticity due to lack of fit is diagnostic of model misspecification and suggests that the logarithmic transformation was not the appropriate metric when the dichotomous training variable was included in LL models.

The mechanisms underlying the age-associated change in VO2 max in healthy men are multifactorial. Factors implicated in the age-associated decline in VO2 max include decreases in maximum heart rate, stroke volume, arteriovenous O2 difference, and skeletal muscle mass, an increase in adiposity, and a decline in daily, regular physical activity (3, 10, 12, 13, 17, 22, 27, 30). In the present study the models adjusted for FFM accounted for more variance than the unadjusted models (Table 3). The unadjusted models yielded larger estimates of the percent decline in VO2 max in the athletes and sedentary men than did models that included FFM. This difference between unadjusted and adjusted models, which has been noted in RS models that do not adjust for muscle mass (8), suggests that ~35% of the decline in VO2 max is due to the age-associated decrease in skeletal muscle mass (OLS, WLS, and LL estimate). This finding is consistent with that of Toth et al. (30), who estimated the contribution to be 33%. Recent findings suggest that the decrease in VO2 max that is associated with the loss of skeletal muscle may be due, at least in trained subjects, to reduced aerobic capacity per kilogram of active muscle (26). Reduced aerobic capacity would result from age-associated changes in maximal O2 delivery and be independent of any actual loss of muscle fibers.

In the present study the OLS and WLS models indicated that the athletes and sedentary men decreased their VO2 max at the same absolute rate, ~0.24 l · min-1 · decade-1. However, the VO2 max was 0.96 l/min higher in the athletes than in the sedentary men at all ages. Although some cross-sectional studies report similar absolute declines in VO2 max over time in athletes and in sedentary individuals (25), other longitudinal studies suggest that VO2 max declines at a slower rate in athletes than in sedentary men (27). Hagberg (10) estimated that the 5.5% decline in VO2 max per decade in master athletes is ~50% of the rate of decline in age-matched sedentary men. It is noteworthy that there is a correlation between the change in training intensity and longitudinal changes in VO2 max (17). Possibly, the attenuation of the rate of the age-associated decrease in VO2 max may be achievable only for a select group of elite older athletes who are able to continue high-intensity training over an extended period of time and also preserve their FFM. The athletes in the present study were heterogeneous with respect to their VO2 max per kilogram of FFM and the intensity and duration of their training. This heterogeneity may have had an impact on the age-associated decline in VO2 max.

A strength of this study is that the athletes and untrained men underwent a vigorous medical evaluation, and only those men with no evidence of cardiovascular or other disease were enrolled. Also, the athletes enrolled in this study were selected only if they were still competitive in their age class. This reduced the potentially confounding effects of disease on the age-associated declines in cardiovascular fitness. Second, individuals with a wide range of obesity and fitness levels were included in the study population. Nevertheless, this study has several limitations. First, the subjects were not randomly selected from the at-large older population, limiting the generalizability of the study findings. The fact that several other studies found similar rates of loss of fitness with age suggests that any bias introduced by our subject-selection process is probably small. Another limitation was the use of hydrodensitometry as the method of assessing FFM. Hydrodensitometry does not yield a direct measurement of skeletal muscle mass; muscle mass must be calculated from the observed density. This calculation depends on several assumptions. In an aging population, changes in bone density and residual lung volume may confound the hydrodensitometric estimate of FFM and, hence, the contribution of FFM and fat mass to the age-associated decline in VO2 max (18). More direct measures of skeletal muscle mass, such as that provided by magnetic resonance imaging or dual X-ray absorptiometry, may provide a more accurate quantification of muscle mass and prediction of the age-associated decline in VO2 max. Third, younger men were not included in this study, which has affected the estimates of the intercept. Finally, training intensity was treated as a dichotomous variable. This may not adequately account for the heterogeneity in effects of exercise training and leisure time activities in the sedentary and athletic populations. Toth et al. (30) concluded that controlling for leisure time activity reduced the degree of decline in VO2 max in sedentary males.

In this study the OLS and WLS models possessed certain advantages over the corresponding RS and LL models. First, OLS and WLS were able to provide estimates of the contribution of the loss of FFM to the age-associated decline in VO2 max, which the RS model, without an explicit FFM term, could not. Another advantage of OLS and WLS was their suitability for testing the hypothesis of parallel linear declines in VO2 max in athletic and sedentary individuals; the nonlinear LL model was not appropriate for addressing this question. OLS or WLS should prove useful in studies where these issues (or similar ones) comprise part of the investigation, with WLS providing a slightly more efficient analysis.

    ACKNOWLEDGEMENTS

We acknowledge the contributions of Drs. E. Bleecker, P. Coon, J. Fleg, R. Pratley, M. J. Busby-Whitehead, and D. Drinkwater and the research exercise physiologists who assisted in measuring VO2 max and body composition in the subjects in this study. In addition, we thank Drs. A. Gardner, J. R. Hebel, and A. Yataco for helpful comments and suggestions.

    FOOTNOTES

This work was supported by National Institute on Aging (NIA) Grant R01-AG-07660, The Johns Hopkins Academic Teaching Nursing Home Award P01-AG-04402, Grant K07-AG-00608, the Department of Veterans Affairs Geriatric Research, Education, and Clinical Center (GRECC), The Johns Hopkins Bayview GCRC (Grant M01-RR-02719), the Claude D. Pepper Older Americans Independence Center NIA Grant P60-AG-12583, and National Institutes of Health Intramural Funds from the Gerontology Research Center, Laboratory of Clinical Investigation, Metabolism Section, NIA.

Present address and address for reprint requests: M. J. Rosen, 42 Haymarket Ln., Bryn Mawr, PA 19010.

Received 29 May 1997; accepted in final form 5 February 1998.

    REFERENCES
Top
Abstract
Introduction
Materials
Results
Discussion
References

1.   Albrecht, G. H., B. R. Gelvin, and S. E. Hartman. Ratios as a size adjustment in morphometrics. Am. J. Phys. Anthropol. 91: 441-468, 1993[Medline].

2.   Allison, D. B., F. Paultre, M. I. Goran, E. T. Poehlman, and S. B. Heymsfield. Statistical considerations regarding the use of ratios to adjust data. Int. J. Obes. Relat. Metab. Disord. 19: 644-652, 1995[Medline].

3.   Badenhop, D. T., P. A. Cleary, S. F. Schaal, E. L. Fox, and R. L. Bartels. Physiological adjustments to higher- and lower-intensity exercise in elders. Med. Sci. Sports Exerc. 15: 496-502, 1983[Medline].

4.   Box, G. E. P., and D. R. Cox. An analysis of transformations. J. R. Stat. Soc. B 26: 211-252, 1964.

5.   Bruce, R. A., and T. R. Horsten. Exercise testing in the evaluation of patients with ischemic heart disease. Prog. Cardiovasc. Dis. 11: 371-390, 1969[Medline].

6.   Buskirk, E. R., and J. L. Hodgson. Age and aerobic power: the rate of change in men and women. Federation Proc. 46: 1824-1829, 1987[Medline].

7.   Ewald, G. A., and C. R. McKenzie (Editors). Manual of Medical Therapeutics (28th ed.). New York: Little, Brown, 1995, p. 577.

8.   Fleg, J. L., and E. G. Lakatta. Role of muscle loss in the age-associated reduction in VO2 max. J. Appl. Physiol. 65: 1147-1151, 1988[Abstract/Free Full Text].

9.   Goran, M. I., D. B. Allison, and E. T. Poehlman. Issues relating to normalization of body fat content in men and women. Int. J. Obes. Relat. Metab. Disord. 19: 638-643, 1985.

10.   Hagberg, J. M. Effect of training on the decline of VO2 max with aging. Federation Proc. 46: 1830-1833, 1987[Medline].

11.   Harvey, A. C. Estimating regression models with multiplicative heteroscedasticity. Econometrica 44: 461-465, 1976.

12.   Heath, G. W., J. M. Hagberg, A. A. Ehsani, and J. O. Holloszy. A physiological comparison of young and older endurance athletes. J. Appl. Physiol. 51: 634-640, 1981[Abstract/Free Full Text].

13.   Holloszy, J. O., and W. M. Kohrt. Exercise. In: Handbook of Physiology. Aging. Bethesda, MD: Am. Physiol. Soc., 1995, chapt. 24, p. 633-666.

14.   Katzel, L. I., E. R. Bleecker, E. G. Colman, E. M. Rogus, J. D. Sorkin, and A. P. Goldberg. Effects of weight loss vs. aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. JAMA 274: 1915-1921, 1995[Abstract/Free Full Text].

15.   Kennedy, P. A Guide to Econometrics (3rd ed.). Cambridge, MA: MIT Press, 1992, p. 90, 118-119, 130, 131.

16.   Kmenta, J. Elements of Econometrics. New York: Macmillan, 1971, p. 263-264.

17.   Marti, B., and H. Howald. Long-term effects of physical training on aerobic capacity: controlled study of former elite athletes. J. Appl. Physiol. 69: 1451-1459, 1990[Abstract/Free Full Text].

18.   Martin, A., and D. Drinkwater. Variability in the measures of body fat. Assumptions or techniques? Sports Med. 11: 277-288, 1991[Medline].

19.   Nevill, A. M. The need to scale for differences in body size and mass: an explanation of Kleiber's 0.75 mass exponent. J. Appl. Physiol. 77: 2870-2873, 1994[Abstract/Free Full Text].

20.   Nevill, A. M., and R. L. Holder. Scaling, normalizing, and per ratio standards: an allometric modeling approach. J. Appl. Physiol. 79: 1027-1031, 1995[Abstract/Free Full Text].

21.   Nevill, A. M., R. Ramsbottom, and C. Williams. Scaling physiological measurements for individuals of different body size. Eur. J. Appl. Physiol. 65: 110-117, 1992.

22.   Ogawa, T., R. Spina, W. H. Martin III, W. M. Kohrt, K. B. Schechtman, J. O. Holloszy, and A. A. Ehsani. Effects of aging, sex, and physical training on cardiovascular responses to exercise. Circulation 86: 494-503, 1992[Abstract/Free Full Text].

23.   Pearson, K. Mathematical contributions to the theory of evolution on a form of spurious correlation which may arise when indices are used in the measurement of organs. Proc. R. Soc. Lond. B Biol. Sci. 60: 489-497, 1987.

24.   Pindyck, R. S., and D. L. Rubinfeld. Econometric Models and Economic Forecasts. New York: McGraw-Hill, 1976, p. 139-142.

25.   Pollock, M. L., H. S. Miller, and J. Wilmore. Physiological characteristics of champion American track athletes 40 to 75 years of age. J. Gerontol. A Biol. Sci. Med. Sci. 29: 645-649, 1987.

26.   Proctor, D. N., and M. J. Joyner. Skeletal muscle mass and the reduction of VO2 max in trained older subjects. J. Appl. Physiol. 82: 1411-1415, 1997[Abstract/Free Full Text].

27.   Rogers, M. A., J. M. Hagberg, W. H. Martin III, A. A. Ehsani, and J. O. Holloszy. Decline in VO2 max with aging in master athletes and sedentary men. J. Appl. Physiol. 68: 2195-2199, 1990[Abstract/Free Full Text].

28.   Rogers, D. M., B. L. Olson, and J. H. Wilmore. Scaling for the VO2-to-body size relationship among children and adults. J. Appl. Physiol. 79: 958-967, 1995[Abstract/Free Full Text].

29.   Siri, W. E. The gross composition of the body. Adv. Biol. Med. Phys. 4: 239-240, 1956[Medline].

30.   Toth, M. J., A. W. Gardner, P. A. Ades, and E. T. Poehlman. Contribution of body composition and physical activity age-related decline in peak VO2 in men and women. J. Appl. Physiol. 77: 647-652, 1994[Abstract/Free Full Text].

31.   Toth, M. J., M. I. Goran, P. A. Ades, D. B. Howard, and E. T. Poehlman. Examination of data normalization procedures for expressing peak VO2 data. J. Appl. Physiol. 75: 2288-2292, 1993[Abstract/Free Full Text].

32.   Vanderburgh, P. M., M. T. Mahar, and C. H. Chou. Allometric scaling of grip strength by body mass in college-age men and women. Res. Q. Exerc. Sport 66: 8-84, 1995.

33.   Welsman, J. R., N. Armstrong, A. M. Nevill, E. M. Winter, and B. J. Kirby. Scaling peak VO2 for differences in body size. Med. Sci. Sports Exerc. 28: 259-265, 1996[Medline].

34.   White, H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrics 48: 817-838, 1980.

35.   Yataco, A. R., J. Busby-Whitehead, D. T. Drinkwater, and L. I. Katzel. Relationship of body composition and cardiovascular fitness to lipoprotein lipid profiles in master athletes and sedentary men. Aging Clin. Exp. Res. 9: 88-94, 1997.


J APPL PHYSIOL 84(6):2163-2170



This article has been cited by other articles:


Home page
AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
R. F. Zoeller Jr.
Gender Differences in Cardiorespiratory Fitness With Advancing Age: Is the Age-Associated Decline in VO2max More Rapid in Men and Do Older Men and Women Respond Differently to Exercise?
American Journal of Lifestyle Medicine, November 1, 2008; 2(6): 492 - 499.
[Abstract] [PDF]


Home page
J. Appl. Physiol.Home page
E. P. Weiss, R. J. Spina, J. O. Holloszy, and A. A. Ehsani
Gender differences in the decline in aerobic capacity and its physiological determinants during the later decades of life
J Appl Physiol, September 1, 2006; 101(3): 938 - 944.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. G. Koch, C. L. Green, A. D. Lee, J. E. Hornyak, G. T. Cicila, and S. L. Britton
Test of the principle of initial value in rat genetic models of exercise capacity
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R466 - R472.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. E. Pimentel, C. L. Gentile, H. Tanaka, D. R. Seals, and P. E. Gates
Greater rate of decline in maximal aerobic capacity with age in endurance-trained than in sedentary men
J Appl Physiol, June 1, 2003; 94(6): 2406 - 2413.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
ATS/ACCP Statement on Cardiopulmonary Exercise Testing
Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 211 - 277.
[Full Text] [PDF]


Home page
ThoraxHome page
J E Cotes, D J Chinn, and J W Reed
Body mass, fat percentage, and fat free mass as reference variables for lung function: effects on terms for age and sex
Thorax, November 1, 2001; 56(11): 839 - 844.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
L. I Katzel, J. D Sorkin, C. C Powell, and A. W Gardner
Comorbidities and exercise capacity in older patients with intermittent claudication
Vascular Medicine, August 1, 2001; 6(3): 157 - 162.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosen, M. J.
Right arrow Articles by Katzel, L. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosen, M. J.
Right arrow Articles by Katzel, L. I.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online